ArticleObesity science & practice2026
Prevalence, Comorbidities, and Mortality of Obesity Classes 4 and 5 in Adults.
Article in Obesity science & practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Introduction: Adult obesity has reached epidemic proportions globally. Although the prevalence and comorbidities of standard obesity classes (classes 1-3, BMI 30-49.9 kg/m Objective: The objective of this study was to determine the prevalence of obesity classes 4 and 5, or extremely severe obesity, in adults over time and to investigate the relationship between extremely severe obesity and metabolic comorbidities and mortality. Methods: Data from nationally representative samples from National Health and Nutrition Examination Surveys from 2000 through 2023 involving 54,793 adults aged 18-65 years in the US were analyzed, including mortality data from 43,454 adults. Results: The prevalence of obesity classes 4 and 5 increased by over 250% from 0.6% in 2000 to 2.2% in 2023 ( Conclusions: The findings highlight the rise of a so far insufficiently characterized obesity entity, extremely severe obesity, and underline the strong association of extremely severe obesity with severe metabolic complications including death. These results emphasize the need for immediate public health interventions to address obesity, particularly obesity classes 4 and 5.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.